Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F13640 in central neuropathic pain after spinal cord injury
2007-003230-42Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in central neuropathic pain (CNP) comparing F13640 with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jul 2007; status: completed.
02
Drugs
NLX-112
03
Conditions
central neuropathic pain (CNP)
Beyond the preview
Go deeper on 2007-003230-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003230-42.